Meeting
2013 ASCO Annual Meeting
Periodontal health in early-stage postmenopausal breast cancer survivors on aromatase inhibitors.
Authors
L. Susan Taichman
University of Michigan, Ann Arbor, MI
L. Susan Taichman , Marita Inglehart , William Giannobile , Thomas Braun , Giselle Kolenic , Catherine Van Poznak
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Clinical Trial Registration Number
NCT01693731
Citation
J Clin Oncol 31, 2013 (suppl; abstr 568)
DOI
10.1200/jco.2013.31.15_suppl.568
Abstract #
568
Poster Bd #
4G
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
An analysis of vitamin D (Vit D) and serum estrogens in postmenopausal (PM) breast cancer (BC) patients receiving aromatase inhibitors (AIs).
First Author: D. W. Cescon
Poster
2020 ASCO Virtual Scientific Program
Dementia risk among post-menopausal women treated with endocrine therapy for early-stage breast cancer in Ontario, Canada.
First Author: Phillip S. Blanchette
Poster
2015 ASCO Annual Meeting
Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls.
First Author: Kathy Pan
Poster
2022 ASCO Quality Care Symposium
Multiscale modeling intervention development and perspectives from early-stage breast cancer survivors on technology to improve long-term adherence to endocrine therapy.
First Author: Manuel Gonzales